Long-term patient-reported outcomes among patients undergoing revascularization vs medical therapy for intermittent claudication
Journal of Vascular Surgery · 2024
DOI: 10.1016/j.jvs.2024.03.455 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Vascular Surgery, 2024. Verfasst von Teryn A Holeman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular Surgery, University of Utah, School of Medicine, Salt Lake City, UT; Department of Population Health Science, University of Utah…. Hauptthemen laut MEDLINE: Intermittent Claudication, Patient Reported Outcome Measures, Peripheral Arterial Disease, Recovery of Function. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, NHLBI.
Abstract (Originalsprache)
OBJECTIVE: Society for Vascular Surgery guidelines recommend revascularization for patients with intermittent claudication (IC) if it can improve patient function and quality of life. However, it is still unclear if patients with IC achieve a significant functional benefit from surgery compared with medical management alone. This study examines the relationship between IC treatment modality (operative vs nonoperative optimal medical management) and patient-reported outcomes for physical function (PROMIS-PF) and satisfaction in social roles and activities (PROMIS-SA). METHODS: We identified patients with IC who presented for index evaluation in a vascular surgery clinic at an academic medical center between 2016 and 2021. Patients were stratified based on whether they underwent a revascularization procedure during follow-up vs continued nonoperative management with medication and recommended exercise therapy. We used linear mixed-effect models to assess the relationship between treatment modality and PROMIS-PF, PROMIS-SA, and ankle-brachial index (ABI) over time, clustering among repeat patient observations. Models were adjusted for age, sex, diabetes, Charlson Comorbidity Index, Clinical Frailty Score, tobacco use, and index ABI. RESULTS: A total of 225 patients with IC were identified, of which 40% (n = 89) underwent revascularization procedures (42% bypass; 58% peripheral vascular intervention) and 60% (n = 136) continued nonoperative management. Patients were followed up to 6.9 years, with an average follow-up of 5.2 ± 1.6 years. Patients who underwent revascularization were more likely to be clinically frail (P = .03), have a lower index ABI (0.55 ± 0.24 vs 0.72 ± 0.28; P < .001), and lower baseline PROMIS-PF score (36.72 ± 8.2 vs 40.40 ± 6.73; P = .01). There were no differences in patient demographics or medications between treatment groups. Examining patient-reported outcome trends over time; there were no significant differences in PROMIS-PF between groups, trends over time, or group differences over time after adjusting for covariates (P = .07, P = .13, and P =.08, respectively). However, all patients with IC significantly increased their PROMIS-SA over time (adjusted P = .019), with patients managed nonoperatively more likely to have an improvement in PROMIS-SA over time than those who underwent revascularization (adjusted P = .045). CONCLUSIONS: Patient-reported outcomes associated with functional status and satisfaction in activities are similar for patients with IC for up to 7 years, irrespective of whether they undergo treatment with revascularization or continue nonoperative management. These findings support conservative long-term management for patients with IC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Vascular Surgery, University of Utah, School of Medicine, Salt Lake City, UT; Department of Population Health Science, University of Utah, School of Medicine, Salt Lake City, UT. Electronic address: teryn.ho…
- Division of Vascular Surgery, University of Utah, School of Medicine, Salt Lake City, UT.
- Department of Population Health Science, University of Utah, School of Medicine, Salt Lake City, UT.
- Division of Vascular Surgery, University of Utah, School of Medicine, Salt Lake City, UT; Department of Population Health Science, University of Utah, School of Medicine, Salt Lake City, UT.
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
- NHLBI
Zitieren
APA
Holeman, T. A., Chester, C., Hales, J. B., Zhang, Y., Johnson, C. E., & Brooke, B. S. (2024). Long-term patient-reported outcomes among patients undergoing revascularization vs medical therapy for intermittent claudication. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2024.03.455
Vancouver
Holeman TA, Chester C, Hales JB, Zhang Y, Johnson CE, Brooke BS. Long-term patient-reported outcomes among patients undergoing revascularization vs medical therapy for intermittent claudication. Journal of Vascular Surgery. 2024. doi:10.1016/j.jvs.2024.03.455
BibTeX
@article{Holeman2024,
author = {Holeman, Teryn A and Chester, Cassidy and Hales, Julie B and Zhang, Yue and Johnson, Cali E and Brooke, Benjamin S},
title = {Long-term patient-reported outcomes among patients undergoing revascularization vs medical therapy for intermittent claudication},
journal = {Journal of Vascular Surgery},
year = {2024},
doi = {10.1016/j.jvs.2024.03.455}
}
EUVIMED